Evidence map›Paper›PMID 30963999›Full record

ArticleeLife2019

Intergenerational epigenetic inheritance of cancer susceptibility in mammals.

Bluma J Lesch, Zuzana Tothova, Elizabeth A Morgan, Zhicong Liao, Roderick T Bronson, Benjamin L Ebert, David C Page

Open access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Environmental and Genetic Perturbations of the Sperm Epigenome.Advances in experimental medicine and biology · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Epigenetic Regulation in Drosophila Tumor Models.Advances in experimental medicine and biology · 2025
    Review
  15. Review
  16. Article
  17. Epigenetic priming in the male germline.Current opinion in genetics & development · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Bluma J LeschWhitehead Institute, Cambridge, United States.ORCID 0000-0002-6689-0240
Zuzana TothovaDepartment of Medicine, Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, United States.
Elizabeth A MorganDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, United States.
Zhicong LiaoDepartment of Genetics, Yale School of Medicine, New Haven, United States.
Roderick T BronsonDepartment of Pathology, Tufts University School of Medicine and Veterinary Medicine, North Grafton, United States.
Benjamin L EbertDepartment of Medicine, Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, United States.
David C PageWhitehead Institute, Cambridge, United States.ORCID 0000-0001-9920-3411
Broad Institute · USBrigham and Women's Hospital · USHoward Hughes Medical Institute · USTufts University · USWhitehead Institute for Biomedical Research · USYale Cancer Center · US

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI JENNIFER W MACK · 1985 to 2026
$330.6M
Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical OncologyK12CA087723 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI David Tsai Ting · 2002 to 2026
$17.9M
Tyrosine Kinases, Serine-Threonine Kinases,&Phosophatases in PathogenesisP01CA108631 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KORNBLAU, STEVEN M · 2005 to 2009
$9.7M
Functional Genomic Dissection of Refractory AnemiaR01HL082945 · NHLBI · DANA-FARBER CANCER INSTITUTE · PI EBERT, BENJAMIN LEVINE · 2005 to 2022
$6.8M
Investigating the Mechanisms of Cohesinopathy in Myelodysplastic SyndromesK08HL140138 · NHLBI · DANA-FARBER CANCER INST · PI TOTHOVA, ZUZANA · 2018 to 2020
$444k
NCI NIH HHS K12 CA087723NCI NIH HHS P01 CA108631NCI NIH HHS P30 CA006516NHLBI NIH HHS K08 HL140138NHLBI NIH HHS R01 HL082945NIH HHS 5K12CA087723-12NIH HHS P01CA108631NIH HHS R01HL082945
6 · The paper itself

Abstract

Susceptibility to cancer is heritable, but much of this heritability remains unexplained. Some 'missing' heritability may be mediated by epigenetic changes in the parental germ line that do not involve transmission of genetic variants from parent to offspring. We report that deletion of the chromatin regulator

Indexed as

Epigenesis, GeneticGenetic Predisposition to DiseaseWillsAnimalsDisease Models, AnimalHistone DemethylasesMiceNeoplasmsHistone DemethylasesUtx protein, mousecancerchromosomesepigeneticsgametesgene expressionhistone modificationmousespermatogenesistransgenerational inheritance

Identifiers

PMID30963999
PMCPMC6456297
OpenAlexW2939867268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.